Cite
HARVARD Citation
Wantoch, M. et al. (2022). Oncolytic virus treatment differentially affects the CD56dim and CD56bright NK cell subsets in vivo and regulates a spectrum of human NK cell activity. Immunology. 166 (1), pp. 104-120. [Online].